If your LH is high or low, begin with three questions: Which reference range applies to you? What did testosterone or estradiol show? Is there a physiologic or medication context that should raise or suppress LH? LH measures the pituitary signal, not the response, so the flag alone cannot locate a problem.
Luteinizing hormone (LH, also spelled luteinising hormone; historically lutropin) is a gonadotropin made by the anterior pituitary. The hypothalamus controls its release through gonadotropin-releasing hormone (GnRH), and sex hormones feed back on the axis. LH shares an alpha subunit with FSH, TSH, and hCG; LH and hCG act through the same receptor.
In women, LH supports the ovarian cells that supply androgen precursors for estradiol production. Its mid-cycle surge triggers ovulation and formation of the progesterone-producing corpus luteum. In men, LH acts on Leydig cells in the testes to drive testosterone synthesis. This is why LH appears in evaluations of irregular periods, infertility, suspected hypogonadism, pituitary disease, and ovulation timing.
Reference ranges (IU/L)
Commonly cited serum LH ranges, by group:
| Group | Range (IU/L) |
|---|---|
| Follicular phase | 1.9 – 12.5 |
| Mid-cycle peak | 8.7 – 76.3 |
| Luteal phase | 0.5 – 16.9 |
| Pregnancy | below 1.5 |
| Postmenopause | 15.9 – 54.0 |
| Using hormonal contraceptives | 0.7 – 5.6 |
| Men, 20 to 70 years | 0.7 – 7.9 |
| Men, over 70 years | 3.1 – 34.0 |
Ranges are assay-dependent and genuinely vary between laboratories. On its current platform, Mayo Clinic Laboratories lists 1.3 – 9.6 IU/L for adult men, 1.9 – 14.6 in the follicular phase, 12.2 – 118.0 at mid-cycle, 0.7 – 12.9 in the luteal phase, and 5.3 – 65.4 after menopause. The range printed on your own report is the primary comparison because it belongs to the assay that measured your sample. Units are numerically equivalent whether reported as IU/L or mIU/mL.
At a Glance
LH is the pituitary's signal to the ovaries or testes. Normal values differ so much by sex, age, menstrual phase, and menopause status that the same number can be reassuring in one person and important in another. A high value may represent compensation for low ovarian or testicular output, an ovulatory surge, or expected menopause physiology. A low value may reflect insufficient hypothalamic-pituitary signaling or normal feedback from testosterone therapy, anabolic steroids, hormonal contraception, or pregnancy.
If you remember only one thing
LH is the signal, not the output. First choose the applicable reference range and physiologic context. Then use testosterone or estradiol to see the response, with FSH helping localize the source when needed.
How LH and FSH read together
LH and FSH come from the pituitary, but the most useful interpretation adds the hormone produced downstream and the setting in which the sample was drawn:
| LH and FSH pattern | Downstream hormone or context | Most useful interpretation |
|---|---|---|
| LH high; FSH high | Testosterone or estradiol low | Points toward primary gonadal dysfunction outside expected menopause physiology |
| LH low or inappropriately normal; FSH low or normal | Testosterone or estradiol low | Points upstream toward hypothalamic, pituitary, illness-related, or energy-related suppression |
| LH low | Testosterone normal or high during testosterone or anabolic-steroid use; or expected suppression during hormonal contraception | Normal negative-feedback effect of an external hormone |
| LH rises sharply near mid-cycle | Compatible cycle timing | Consistent with the ovulatory surge, but does not by itself prove ovulation occurred |
| LH and FSH high after menopause | Postmenopausal life stage | Expected physiology rather than ovarian disease |
| LH high relative to FSH | Irregular cycles or hyperandrogenism | Can occur in PCOS, but is neither required nor diagnostic |
The LH-to-FSH ratio is a pattern hint, not a test for PCOS. Current diagnostic criteria use two of three features after excluding other causes: clinical or biochemical hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphology by ultrasound or, in adults, an elevated AMH used in place of ultrasound. LH and the LH-to-FSH ratio are not among those criteria. Hormone testing is also not routinely needed to identify natural menopause in otherwise healthy people aged 45 or over with typical symptoms; when biochemical confirmation is appropriate, FSH is used rather than LH.
Two people with the same result
A worked hypothetical: two people each receive an LH result of 15 IU/L. The first is a 52-year-old woman whose FSH on the same draw is 70 IU/L and whose periods stopped a year ago; her LH fits expected menopause physiology. The second is a 28-year-old man whose morning testosterone on the same draw is below his lab's range; the identical LH value now suggests the pituitary is increasing its signal while testicular output remains low. Same number, different meaning, separated by the response hormone and life stage.
What this result cannot tell you
A serum LH value cannot confirm or rule out pregnancy; that is hCG's job, and LH is expected to be low in pregnancy. A single LH result also cannot prove that ovulation occurred: urinary LH kits identify a surge that generally precedes ovulation by 1 to 2 days but provide indirect evidence, while appropriately timed luteal progesterone provides evidence of recent ovulation. LH alone cannot distinguish a surge from menopause, primary gonadal dysfunction from a central signaling problem, or medication feedback from disease. Without cycle or life-stage context and the relevant companion hormones, a mildly out-of-range result may remain uninterpretable.
Common interpretation mistakes
The first mistake is using the wrong range: a mid-cycle result judged against a follicular-phase interval can look abnormal when it is not. The second is reading LH without its response hormone; even a "normal" LH may be inappropriately normal when testosterone or estradiol is low. Other errors include treating postmenopausal elevation as disease, overlooking expected suppression from hormonal contraception or testosterone therapy, using the LH-to-FSH ratio as a PCOS test, and comparing values across laboratories as if assay ranges were interchangeable. IU/L and mIU/mL are numerically equivalent, but the reference intervals may differ.
Questions your doctor may ask
Your doctor may ask where you were in your menstrual cycle on the day of the draw, when your last period occurred, and whether pregnancy is possible. They will want to know about hormonal contraception, testosterone, anabolic steroids, fertility medications, recent illness, major weight change, and training or underfueling. Symptoms help direct the next step: missed periods or hot flashes; low libido or fertility difficulty; headaches, vision changes, or nipple discharge. Bring prior LH, FSH, estradiol, and testosterone results. Ask your testing laboratory about biotin-containing supplements; Mayo requests a 12-hour pause before its assay.
Read together with
FSH is a frequent companion because it helps separate primary gonadal dysfunction from reduced hypothalamic-pituitary signaling. In men, interpret LH with morning total testosterone, repeating testosterone when low; free testosterone may help when indicated, and prolactin is added when a central pattern is suspected. In women, add estradiol and cycle timing; use hCG when pregnancy is possible and luteal progesterone when the question is whether ovulation recently occurred. Prolactin and TSH are selected according to menstrual history and symptoms rather than ordered automatically for every LH result.
Clinical pearls
Mayo Clinic Laboratories asks patients to avoid biotin-containing supplements for 12 hours before collection for its assay; follow the instructions from the laboratory performing your test. A low or normal LH is not reassuring when testosterone or estradiol is low, because the pituitary response may be inappropriately weak. Mayo notes that postmenopausal LH is generally above 40 IU/L on its platform, but its postmenopausal reference interval is broad and assay-specific. To document recent ovulation, serum progesterone is generally drawn about 1 week before the expected next period; a single value can provide evidence of ovulation but cannot assess luteal-phase quality.
Clinical Takeaway
LH measures the strength of a pituitary signal, not the success of the response. First choose the correct range for sex, age, cycle phase, and life stage. Then use testosterone or estradiol to assess the response, FSH to help localize the source when needed, and symptoms, medications, and pregnancy status to test the interpretation. That sequence separates expected physiology and hormone feedback from primary gonadal dysfunction or insufficient hypothalamic-pituitary signaling.
In one sentence
LH tells you how strongly the pituitary is signaling; the correct range, FSH, testosterone or estradiol, and physiologic context tell you what that signal means.
Bottom line
Do not diagnose from the LH flag alone. High LH with low testosterone points toward a testicular-level cause; low or inappropriately normal LH with low testosterone or estradiol points upstream; and high LH with high FSH may be expected after menopause but needs evaluation with menstrual disturbance before age 40. A mid-cycle surge, pregnancy, hormonal contraception, and testosterone use can explain an out-of-range value. Review an unexplained or persistent pattern with your clinician using the companion hormones and context from the same draw.
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →Frequently Asked Questions
What does high LH mean in men?
What does low LH mean in men?
What does high LH mean in women?
Is LH high in PCOS, and what is the LH-to-FSH ratio?
What LH level indicates ovulation?
What are normal LH levels in menopause?
Can an LH test confirm pregnancy?
What is a normal LH level?
All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.
-
Luteinizing Hormone (LH), Serum — Test ID: LH
-
Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline
-
Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline
-
Fertility evaluation of infertile women: a committee opinion
-
Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome
-
Evidence-based guideline: premature ovarian insufficiency
-
Extensive monitoring of the natural menstrual cycle using the serum biomarkers estradiol, luteinizing hormone and progesterone
-
Luteinizing Hormone — Test Overview
-
Luteinizing Hormone — Reference Values
-
Menopause: identification and management — Recommendations